Here is my take for what it's worth. The charts show a downward pattern. Many traders use computer generated programs. A lot of day or short term traders use the pinx. There is nothing wrong with that if you know what you are doing. This may be the reason the price is up and down. (Look at yesterday 4/5/14. It seemed like profit taking to me.)There are a lot of press releases from NVLX, but until recently no real news and that is scary for a pump and dump scam in the works for which penny stocks are notorious. However, charts (and real non - press release news) aside which in my opinion are self professing, it is the fundamentals and supply and demand which eventually, in the end, determine if a stock is a winner or a loser.
Again, charts trends aside here is what I am interested in, Translational Drug Development AKA TD2 and Dr. Daniel Von Hoff. Both are impressive. TD2 is not a fly by night operation to say the least. Dr. Daniel Van Hoff is the icing on the cake. Now here is a guy with the credentials including the Mayo clinic on his resume. This is not to mention one of the foremost oncologists in the country. If the drug, or should I say technique, that NVLX is proposing to put on the market passes muster, LOOK OUT! A major winner. If it fizzes out, it's a bust. As a buy and hold trader who really does not like small caps, I say this is a good gamble due to Dr. Hoff's involvement. This is a guy who is not going to waste his time and has a reputation to keep. I don't think he would risk it at this stage of the game in his life. (Google him). And TD2 isn't shabby either. The fact that NVLX only has four employees is a bit disterbing, but they farm everything out which isn't exactly dumb or uncommon in business. It's all only my humble opinion. I'm in on the long side. Good luck to all.
Market Data 
Markets 
AI
